Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.40    0.20 (0.26%)
Bid:
78.15
Ask:
80.10
Spread: 1.95 (2.495%)
Market Cap: £1.50b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

17 May 2023 07:00

RNS Number : 6443Z
Coats Group PLC
17 May 2023
Ā 

Ā 

Ā 

Ā 17 May 2023

Coats Group plc

Ā 

Trading update

Trading in line with full year expectations

Ā 

Coats Group plc ('Coats', the 'Company' or the 'Group'), the world's leading industrial threadĀ and global footwear componentĀ manufacturer, today announces a trading update for the period 1 January 2023 to 30 April 2023 ('the period').

Ā 

Ā· Market conditions and Group trading in the period were in line with our expectations

Ā· Constant currency revenue decline of 7%, with organic CER revenues down 20%, against a very strong prior year comparator

Ā· Operating profit margins were resilient, supported by strategic projects and tight cost control

Ā· Full year expectations unchanged

Ā 

1st January to 30th April 2023 vs same period in 2022

Reported

CER

Organic CER

Apparel

-27%

-22%

-22%

Footwear

58%

62%

-23%

Performance Materials

-16%

-13%

-13%

Total

-12%

-7%

-20%

Ā 

All following references are on an CER basis unless specified.

Ā 

The organic revenue decline of 20% in the period, against a very strong prior year comparator, reflects the continuation of the widespread industry destocking in Apparel and Footwear, together with previously disclosed customer contract in-sourcing in Performance Materials. This was in part offset by the annualised contribution from the prior year acquisitions in Footwear, with overall revenue declining by 7%.

As expected, Apparel revenues declined by 22% in the period reflecting a continuation of trends seen in Q4 2022, with destocking by customers adjusting to more subdued consumer demand and excess inventory levels.

Ā 

Footwear revenue decreased by 23% organically, with similar destocking drivers to those seen in the Apparel markets. Reported divisional revenue increased by 58% year-on-year in the period, including the first time contribution from the acquisitions of Texon and Rhenoflex. The integration of both businesses is progressing to plan, with the realisation of synergy and efficiency benefits increasing, in line with expectations.

Ā 

Revenue in Performance Materials reduced by 13% in the period. This was largely the result of the customer insourcing of a significant PPE contract in H2 2022.

Ā 

Our strategic projects remain on-track and are delivering significant operational and financial benefits. These actions, alongside dynamic pricing, have supported operating margins at the beginning of 2023 and will continue to do so. Cash generation continues to be positive and a focus for the Group.

Ā 

Ā 

Outlook

Ā 

With trading in the period in line with expectations we continue to anticipate full year 2023 performance consistent with the Board's expectations, with a second-half weighting, underpinned by the contribution from acquisitions, associated synergies and strategic projects.

Ā 

With a significantly strengthened commercial and operational platform, the Group remains very well-positioned in its markets, as the global partner of choice for winning brands and with a clear leadership position in innovation and sustainability.Ā Consequently, we remain excited about the growth and margin opportunities across the Group over the medium term, with improved cash generation providing an additional catalyst to our strategic ambitions.

Ā 

The Group will release its interim results on 1 August 2023.

Ā 

Ā 

Ā 

Ā 

Ā 

Enquiry details

Ā 

Ā 

Ā 

Investors

Chris Dyett / Victoria Huxster

Coats Group plc

+44 (0)797 497 4690

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

Ā 

Ā 

About Coats Group plc

Coats is a world leader in thread manufacturing and structural components for apparel and footwear, as well as an innovative pioneer in performance materials. These critical solutions are used to create a wide range of products, including ones that provide safety and protection for people, data and the environment. Headquartered in the UK, Coats is a FTSE250 company and a FTSE4Good Index constituent. Revenue in 2022 was $1.6 billion. Trusted by the world's leading companies to deliver crucial, innovative, and sustainable solutions, Coats provides value-adding products including apparel, accessory and footwear threads, structural footwear components, fabrics, yarns and software applications. Customer partners include companies from the apparel, footwear, automotive, telecoms, personal protection, and outdoor goods industries. With a proud heritage dating back more than 250 years and spirit of evolution to constantly stay ahead of changing market needs, Coats has operations across some 50 countries with a workforce of 17,000, serving its customers worldwide. Coats connects talent, textiles, and technology, to make a better and more sustainable world. Worldwide, there are three dedicated Coats Innovation Hubs, where experts collaborate with partners to create the materials and products of tomorrow. It participates in the UN Global Compact and is committed to Science Based sustainability targets for 2030 and beyond, with an aspiration of achieving net-zero by 2050. Coats is also committed to achieving its goals in Diversity, Equity & Inclusion, workplace health & safety, employee & community wellbeing, and supplier social performance. To find out more about Coats visit www.coats.com.

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
TSTNKABQCBKDPPD
Date   Source Headline
4th Mar 20217:00 amRNS2020 Full Year Results
3rd Mar 20217:00 amRNSRemuneration and Audit Committee Changes
26th Feb 202110:52 amRNSTotal Voting Rights
2nd Feb 202111:30 amRNSHolding(s) in Company
28th Jan 202111:07 amRNSHolding(s) in Company
31st Dec 20201:31 pmRNSTotal Voting Rights
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20204:05 pmRNSDirector/PDMR Shareholding
26th Nov 202011:11 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSNew Chairman appointment
23rd Nov 20202:29 pmRNSHolding(s) in Company
5th Nov 202012:36 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
14th Oct 20207:00 amRNSConfirmation of CFO Designate start date
6th Oct 202011:09 amRNSBlock listing Interim Review
22nd Sep 20207:00 amRNSDirector Declaration
13th Aug 20207:00 amRNSHalf-year Report
29th Jul 20207:00 amRNSAppointment of Chief Financial Officer Designate
29th Jun 20209:25 amRNSHolding(s) in Company
11th Jun 20203:17 pmRNSResult of AGM
27th May 20204:47 pmRNSDirector/PDMR Shareholding
20th May 20207:00 amRNSTrading Statement
18th May 20202:28 pmRNSNotice of AGM
18th May 202010:03 amRNSDirectorate Change
13th May 20203:06 pmRNSNotice of AGM
28th Apr 20205:24 pmRNSHolding(s) in Company
28th Apr 20201:21 pmRNSNotice of AGM
27th Apr 20202:01 pmRNSDisclosure of rights attached to securities
23rd Apr 20201:48 pmRNSHolding(s) in Company
3rd Apr 20202:13 pmRNSBlock listing Interim Review
2nd Apr 20204:30 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSDirectorate Change
27th Mar 20207:00 amRNSTrading Statement
24th Mar 20204:19 pmRNSHolding(s) in Company
23rd Mar 20209:48 amRNSHolding(s) in Company
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20202:52 pmRNSDirector/PDMR Shareholding
12th Mar 202010:46 amRNSDirector/PDMR Shareholding
11th Mar 202010:14 amRNSHolding(s) in Company
10th Mar 20201:31 pmRNSAnnual Financial Report
9th Mar 20208:13 amRNSDirector/PDMR Shareholding
6th Mar 20202:18 pmRNSDirector/PDMR Shareholding
6th Mar 20202:17 pmRNSDirector/PDMR Shareholding
6th Mar 20208:23 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 202011:03 amRNSAdditional Listing
28th Feb 20203:48 pmRNSTotal Voting Rights
14th Feb 20201:29 pmRNSHolding(s) in Company
11th Feb 20207:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.